Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,773 public trials 496 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Advanced Melanoma in Russian Experience

NCT03663647

Conditions
BRAF V600 Mutation, Cutaneous Melanoma, Stage IV, Melanoma, +11 more
Locations
  • Moscow Regional Oncologic Dispensary Balashikha, Russia
  • Belgorod Oncologic Dispensary Belgorod, Russia
  • Republican Clinical Oncologic Dispensary Cheboksary, Russia
  • Kaluga Regional Clinical Oncologic Dispensary Kaluga, Russia
View Trial Details
Completed

An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma

NCT03068455

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • The Angeles Clinic & Research Institute Los Angeles, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
View all 124 locations
View Trial Details
Completed

Post-ATU Study of Nivolumab

NCT03325257

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • AP-HP Hôpital Ambroise Paré Paris, Boulogne Billancourt, France
  • CHU de Grenoble Grenoble, La Tronche, France
  • Chu Amiens Amiens, France
  • Hopital St andré-CHU DE Bordeaux Bordeaux, France
View all 17 locations
View Trial Details
Completed

Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma

NCT01335009

Conditions
Melanoma, Metastatic Melanoma, Neoplasm Metastasis, +14 more
Locations
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 29 locations
View Trial Details
Completed

Study of Nivolumab Given Sequentially With Ipilimumab in Subjects With Advanced or Metastatic Melanoma (CheckMate 064)

NCT01783938

Conditions
Advanced or Metastatic Melanoma, Melanoma, Neoplasms, +10 more
Locations
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Indiana University Health Melvin And Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions